<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77582">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02095535</url>
  </required_header>
  <id_info>
    <org_study_id>H14-00623</org_study_id>
    <nct_id>NCT02095535</nct_id>
  </id_info>
  <brief_title>Chlorhexidine Drying Time</brief_title>
  <acronym>Chlorhexidine</acronym>
  <official_title>The Minimum ChloraPrep Drying Time Before Neuraxial Anesthesia in Elective Cesarean Delivery Patients - Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Before a patient gets a spinal/epidural, their lower back is cleaned with an antiseptic
      solution diluted in alcohol called ChloraPrep. ChloraPrep must completely dry before
      starting the anesthetic procedure. It is not known how much time is needed for the solution
      to completely dry. The investigators aim to determine this.

      As the ChloraPrep dries, the alcohol is converted into vapour. The investigators will be
      using a PPBRae 3000 device to detect small amounts of vapours in the air. As the ChloraPrep
      dries it gives off less and less vapour. The investigators will use this diminishing vapour
      concentration to determine when drying is complete.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Length of drying time</measure>
    <time_frame>At Chloraprep application</time_frame>
    <description>Length of drying time from when Chloraprep solution is applied to skin to when skin is deemed dry.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Drying Time</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <description>All study participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine gluconate</intervention_name>
    <description>antiseptic</description>
    <arm_group_label>Study group</arm_group_label>
    <other_name>Chloraprep</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elective cesarean patients at BC Women's Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant

          -  At full term

          -  Due to have a cesarean section under spinal or epidural anesthesia

          -  19 to 40 years of age

        Exclusion Criteria:

          -  Allergy to certain antiseptic solutions

          -  Not suitable for a spinal/epidural anesthetic

          -  Have a significant amount of hair on lower back
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vit Gunka, MD FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BC Women's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <lastchanged_date>September 26, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obstetric patients</keyword>
  <keyword>chloraprep</keyword>
  <keyword>chlorhexidine</keyword>
  <keyword>drying time</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
